ArticleFrontiers in immunology2014

Characterization of Novel PI3Kδ Inhibitors as Potential Therapeutics for SLE and Lupus Nephritis in Pre-Clinical Studies.

Philipp Haselmayer et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.